Abstract
The mutation in the myotonic dystrophy (DM) gene is an expansion in a triplet (CTG)n repeat in the 3′ untranslated region of a novel gene that partially encodes a serine-threonine protein kinase (DMPK), with closest sequence homology to a small subgroup of protein kinases involved in the control of proliferation and cell shape. Expansion of the repeat correlates reasonably well with disease severity and offers a plausible molecular explanation for the previously contentious issue of anticipation. There is considerable heterogeneity in CTG expansion size in different tissues of affected individuals. The consensus of data from many laboratories indicates that DMPK mRNA is most probably downregulated as a consequence of the repeat expansion. Two polypeptides (68/78 kDa) have been shown to be absent in mouse knockout mutants and therefore can be considered as bona fide gene products. Previous data suggesting that 52-55 kDa polypeptides were likely candidates, have been firmly ruled out at the same time. Further results from studies of knockout and overexpressing transgenic mice indicate that neither simple loss nor gain of DMPK expression is sufficient to account for the DM clinical phenotype. One of the most pressing questions now being addressed is how expansion of the CTG repeat within the DMPK gene affects gene expression, not only of DMPK, but of all genes at the 19q13.3 locus: is DMPK actually responsible for the clinical phenotype seen in DM? The identification of both immediate upstream and downstream human genes (59 and DMRHP, respectively) has been an important first step to answering these questions. Only when these matters have been dealt with can one reasonably expect to start to delineate the different metabolic and signalling pathways responsible for the diverse phenotypes that make up the complex clinical picture of DM.
Similar content being viewed by others
REFERENCES
Achiron A, Magal N, Shem-Tov N, Noy S, Shohat M, Gadoth N (1994) Myotonic dystrophy gene analysis in affected Israeli families. Isr J Med Sci 30: 622–625.
Ahringer J, Kimble J (1991) Control of the sperm-oocyte switch in Caenorhabditis elegans hermaphrodites by the fem-3 3′ untranslated region. Nature 349: 346–348.
Anvret M, Ahlberg G, Grandell U, Hedberg B, Johnson K, Edstrom L (1993) Larger expansions of the CTG repeat in muscle compared to lymphocytes from patients with myotonic dystrophy. Hum Mol Genet 2: 1397–1400.
Ashizawa T, Dubel JR, Harati Y (1993) Somatic instability of CTG repeat in myotonic dystrophy. Neurology 43: 2674–2678.
Aslanidis C, Jansen G, Amemiya C, et al (1992) Cloning of the essential myotonic dystrophy region and mapping of the putative defect. Nature 355: 548–551.
Behrens MI, Jalil P, Serani A, Vergara F, Alvarez O (1994) Possible role of apamin-sensitive K+ channels in myotonic dystrophy. Muscle Nerve 17: 1264–1270.
Bird A (1986) CpG-rich islands and the function of DNA methylation. Nature 321: 209–213.
Boucher CA, King SK, Carey N, et al (1995) A novel homeodomain-encoding gene is associated with a large CpG island interrupted by the myotonic dystrophy unstable (CTG)n repeat. Hum Mol Genet 4: 1919–1925.
Brewster BS, Jeal S, Strong PN (1993) Identification of a protein product of the myotonic dystrophy gene using peptide specific antibodies. Biochem Biophys Res Commun 194: 1256–1260.
Brook JD, McCurrach ME, Harley HG, et al (1992) Molecular basis of myotonic dystrophy expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell 69: 385.
Bush EW, Taft CS, Meixell GE, Perryman MB (1996) Overexpression of myotonic dystrophy kinase in BC3H1 cells induces the skeletal muscle phenotype. J Biol Chem 271: 548–552.
Buxton J, Shelbourne P, Davies J, et al (1992) Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy. Nature 355: 547–548.
Carango P, Noble JE, Marks HG, Funanage VL (1993) Absence of myotonic dystrophy protein kinase (DMPK) mRNA as a result of a triplet repeat expansion in myotonic dystrophy. Genomics 18: 340–348.
Dunne PW, Walch ET, Epstein HF (1994) Phosphorylation reactions of recombinant human myotonic dystrophy protein kinase and their inhibition. Biochemistry 33: 10809–10814.
Etongue-Mayer P, Faure R, Bouchard JP, Thibault MC, Puymirat J (1994) The myotonin-protein kinase phosphorylates tyrosine residues in normal human skeletal muscle. Biochem Biophys Res Commun 199: 89–92.
Fu YH, Pizzuti A, Fenwick RG Jr, et al (1992) An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 255: 1256–1258.
Fu YH, Friedman DL, Richards S, et al (1993) Decreased expression of myotonin-protein kinase messenger RNA and protein in adult form of myotonic dystrophy. Science 260: 235–238.
Harley HG, Brook JD, Rundle SA, et al (1992) Expansion of an unstable DNA region and phenotypic variation in myotonic dystrophy. Nature 355: 545–546.
Harley HG, Rundle SA, MacMillan JC (1993) Size of the unstable CTG repeat sequence in relation to phenotype and parental transmission in myotonic dystrophy. Am J Hum Genet 52: 1164–1174.
Harper (1989) Myotonic Dystrophy. London: WB Saunders.
Harper PS, Harley HG, Reardon W, Shaw DJ (1992) Anticipation in myotonic dystrophy new light on an old problem. Am J Hum Genet 51: 10–16.
Hofmann-Radvanyi H, Lavedan C, Rabes JP, et al (1993) Myotonic dystrophy, absence of CTG enlarged transcript in congenital forms, and low expression of the normal allele. Hum Mol Genet 2: 1263–1266.
Hunter A, Tsilfidis C, Mettler G, et al (1992) The correlation of age of onset with CTG trinucleotide repeat amplification in myotonic dystrophy. J Med Genet 29: 774–779.
Imbert G, Kretz C, Johnson K, Mandel JL (1993) Origin of the expansion mutation in myotonic dystrophy. Nature Genet 4: 72–76.
Jansen G, Mahadevan M, Amemiya C, et al (1992) Characterization of the myotonic dystrophy region predicts multiple protein isoform-encoding mRNAs. Nature Genet 1: 261–266.
Jansen G, Bachner D, Coerwinkel M, Wormskamp N, Hameister H, Wieringa B (1995) Structural organization and developmental expression pattern of the mouse WD-repeat gene DMR-N9 immediately upstream of the myotonic dystrophy locus. Hum Mol Genet 4: 843–852.
Jansen G, Groenen PJTA, Bachner D, et al (1996) Abnormal myotonic dystrophy protein kinase levels produce only mild myopathy in mice. Nature Genet 13: 316–324.
Justice RW, Zilian O, Woods DF, Noll M, Bryant PJ (1995) The Drosophila tumor suppressor gene warts encodes a homolog of human myotonic dystrophy kinase and is required for the control of cell shape and proliferation. Genes Dev 9: 534–546.
Kang S, Ohshima K, Shimizu M, Amirhaeri S, Wells RD (1995) Pausing of DNA synthesis in vitro at specific loci in CTG and CGG triplet repeats from human hereditary disease genes. J Biol Chem 270: 27014–27021.
Koga R, Nakao Y, Kurano Y, et al (1994) Decreased myotonin-protein kinase in the skeletal and cardiac muscles in myotonic dystrophy. Biochem Biophys Res Commun 202: 577–585.
Krahe R, Ashizawa T, Abbruzzese C, et al (1995) Effect of myotonic dystrophy trinucleotide repeat expansion on DMPK transcription and processing. Genomics 28: 1–14.
Leung T, Manser E, Tan L, Lim L (1995) A novel serine/threonine kinase binding the Ras-related RhoA GTPase which translocates the kinase to peripheral membranes. J Biol Chem 270: 29051–29054.
Maeda M, Taft CS, Bush EW, et al (1995) Identification, tissue-specific expression, and subcellular localization of the 80-and 71-kDa forms of myotonic dystrophy kinase protein. J Biol Chem 270: 20246–20249.
Mahadevan M, Tsilfidis C, Sabourin L, et al (1992) Myotonic dystrophy mutation: an unstable CTG repeat in the 3′ untranslated region of the gene. Science 255: 1253–1255.
Mahadevan MS, Foitzik MA, Surh LC, Korneluk RG (1993) Characterization and polymerase chain reaction (PCR) detection of an Alu deletion polymorphism in total linkage disequilibrium with myotonic dystrophy. Genomics 15: 446–448.
Novelli G, Gennarelli M, Menegazzo E, et al (1993a) (CTG)n triplet mutation and phenotype manifestations in myotonic dystrophy patients. Biochem Med Metab Biol 50: 85–92.
Novelli G, Gennarelli M, Zelano G, et al (1993b) Failure in detecting mRNA transcripts from the mutated allele in myotonic dystrophy muscle. Biochem Mol Biol Int 29: 291–297.
Reddy S, Smith DBJ, Rich MM, et al (1996) Mice lacking the myotonic dystrophy protein kinase develop a late onset progressive myopathy. Nature Genet 13: 325–335.
Ricker K, Koch MC, Lehmann-Horn F, et al (1994) Proximal myotonic myopathy, a new dominant disorder with myotonia, muscle weakness, and cataracts. Neurology 44: 1448–1452.
Roeder E, Jain K, Timchenko L, et al (1994) Homozygous myotonic dystrophy. Am J Hum Genet 55: A7.
Sabourin LA, Mahadevan MS, Narang M, Lee DS, Surh LC, Korneluk RG (1993) Effect of the myotonic dystrophy (DM) mutation on mRNA levels of the DM gene. Nature Genet 4: 233–238.
Salvatori S, Biral D, Furlan S, Marin O (1994) Identification and localization of the myotonic dystrophy gene product in skeletal and cardiac muscles. Biochem Biophys Res Commun 203: 1365–1370.
Sasagawa N, Sorimachi H, Maruyama K, Arahata K, Ishiura S, Suzuki K (1994) Expression of a novel myotonin protein kinase (MtPK) cDNA clone which encodes a protein with a thymopoetinlike domain in COS cells. FEBS Lett 351: 22–26.
Shaw DJ, McCurrach M, Rundle SA, et al (1993) Genomic organization and transcriptional units at the myotonic dystrophy locus. Genomics 18: 673–679.
Taneja KL, McCurrach M, Schalling M, Housman D, Singer RH (1995) Foci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues. J Cell Biol 128: 995–1002.
Thornton CA, Johnson K, Moxley RT (1994a) Myotonic dystrophy patients have larger CTG expansions in skeletal muscle than in leukocytes. Ann Neurol 35: 104–107.
Thornton CA, Griggs RC, Moxley RT (1994b) Myotonic dystrophy with no trinucleotide repeat expansion. Ann Neurol 35: 269–272.
Timchenko L, Nastainczyk W, Schneider T, Patel B, Hofmann F, Caskey CT (1995) Full-length myotonin protein kinase (72kDa) displays serine kinase activity. Proc Natl Acad Sci USA 92: 5366–5370.
Tsilfidis C, MacKenzie AE, Mettler G, Barcelo J, Korneluk RG (1992) Correlation between CTG trinucleotide repeat length and frequency of severe congenital myotonic dystrophy. Nature Genet 1: 192–195.
van der Ven PF, Jansen G, van Kuppevelt TH, et al (1993) Myotonic dystrophy kinase is a component of neuromuscular junctions. Hum Mol Genet 2: 1889–1894.
Wang J, Pegoraro E, Menegazzo E, et al (1995) Myotonic dystrophy evidence for a possible dominant-negative RNA mutation. Hum Mol Genet 4: 599–606.
Wang YH, Griffith J (1995) Expanded CTG triplet blocks from the myotonic dystrophy gene create the strongest known natural nucleosome positioning elements. Genomics 25: 570–573.
Wang YH, Amirhaeri S, Kang S, Wells RD, Griffith JD (1994) Preferential nucleosome assembly at DNA triplet repeats from the myotonic dystrophy gene. Science 265: 669–671.
Whiting EJ, Waring JD, Tamai K, et al (1995) Characterization of myotonic dystrophy kinase (DMK) protein in human and rodent muscle and central nervous tissue. Hum Mol Genet 4: 1063–1072.
Wieringa B (1994) Myotonic dystrophy reviewed: back to the future? Hum Mol Genet 3: 1–7.
Wightman B, Burglin TR, Gatto J, Arasu P, Ruvkin G (1991) Negative regulatory sequences in the lin-14 3′-untranslated region are necessary to generate a temporal switch during Caenorhabditis elegans development. Genes Dev 5: 1813–1824.
Zatz M, Passos Bueno MR, Cerqueira A, Marie SK, Vainzof M, Pavanello RC (1995) Analysis of the CTG repeat in skeletal muscle of young and adult myotonic dystrophy patients when does the expansion occur? Hum Mol Genet 4: 401–406.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Strong, P.N., Brewster, B.S. Myotonic dystrophy: Molecular and cellular consequences of expanded DNA repeats are elusive. J Inherit Metab Dis 20, 159–170 (1997). https://doi.org/10.1023/A:1005396420442
Issue Date:
DOI: https://doi.org/10.1023/A:1005396420442